investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Optimization of adoptive immunotherapy with autologous CD20-specific T cells

Brian Till

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Kenneth Lynn Wright

Natural Killer Cell Regulation by PRDM1 and IRF4/8

Non-Hodgkin lymphoma

Riccardo Dalla-Favera

Role of Acetyltransferase Gene Inactivation in Follicular Lymphoma Pathogenesis

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Tammy A Morrish

Mechanisms of Subtelomere Recombination in Telomerase Deficient Tumors

Non-Hodgkin lymphoma

Nancy Joan Raab-Traub

Herpesviral, Oncogenesis, Latency and Reactivation

Non-Hodgkin lymphoma

Joseph H Antin

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Non-Hodgkin lymphoma

Keisuke Nagao

Exploring Mechanisms that Govern Immune Homeostasis in Skin

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Rachael Ann Clark

CTCL immunobiology: lessons from alemtuzumab

Non-Hodgkin lymphoma

Mary Ellen Conley

Genetic Etiology of Agammaglobulinemia with Absent B Cells

Non-Hodgkin lymphoma

John Nicholas

BH3-only Protein Targeting by HHV-8

Non-Hodgkin lymphoma

Pathology